XL-388 | Interleukin Related interleukin-related.com

Product Name :
XL-388

Search keywords :
XL388

drugId :
null

Target Vo:
Mammalian target of Rapamycin (mTORC1)

Target Vo Short Name :
mTORC1

Moa_Name:
mTOR Complex 2 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Exelixis Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Myeloproliferative Disorders

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Siltuximab Epigenetic Reader Domain
mTOR Rabbit mAb medchemexpress
HDAC2 Antibody (YA742): HDAC2 Antibody (YA742) is a non-conjugated and Mouse origined monoclonal antibody about 55 kDa, targeting to HDAC2 (2D9). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat, Monkey.

Author: Interleukin Related

Related Posts